遺伝子発現解析市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、手法別、用途別、エンドユーザー別、地域別、競合別、2020-2030年

遺伝子発現解析の世界市場は、2024年に50億2,000万米ドルと評価され、予測期間中にCAGR 7.71％で成長し、2030年には78億4,000万米ドルに達すると予測されています。

この市場は、ライフサイエンスやバイオテクノロジー分野で重要な役割を果たしており、さまざまな生物学的サンプルにおける遺伝子発現を解析するためのツールや技術を提供しています。調査は、創薬や臨床診断から個別化医療や学術研究まで、幅広いアプリケーションの基礎となっています。主要な成長要因は、遺伝子発現プロファイリングが個々の遺伝的シグネチャーの同定に役立ち、より正確で効果的な治療を可能にする個別化治療アプローチに対する需要の高まりです。技術の進歩、特にRNA-Seqのようなハイスループットシーケンスプラットフォームは、前例のない規模でトランスクリプトームを調査する研究者の能力を著しく向上させました。このような技術の採用は、生物医学研究と製薬会社、診断薬開発会社、研究機関間の共同研究の急増に拍車をかけています。腫瘍学では、遺伝子発現ツールがバイオマーカーの発見や治療反応の予測にますます使用されるようになっており、市場の拡大をさらに加速しています。

市場促進要因

シーケンス技術の進歩

主な市場課題

データ解析の複雑さ

主な市場動向

シングルセルRNAシーケンス（scRNA-Seq）

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の遺伝子発現解析市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（機器、サービス、その他）
  • 技術別（RNA発現、プロモーター解析、タンパク質発現および翻訳後修飾発現、その他）
  • 用途別（医薬品の発見と開発、臨床診断、バイオテクノロジーと微生物学、その他）
  • エンドユーザー別（製薬会社、バイオテクノロジー企業、開発調査受託機関（CRO）、学術機関および政府調査機関、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 製品タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の遺伝子発現解析市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の遺伝子発現解析市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の遺伝子発現解析市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の遺伝子発現解析市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの遺伝子発現解析市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の遺伝子発現解析市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Merck KGaA
• Genscript Biotech Corporation
• Qiagen
• Bio-Rad Laboratories
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Agilent Technologies
• Lonza Group Ltd.
• New England Biolabs Inc

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Gene Expression Analysis Market was valued at USD 5.02 billion in 2024 and is projected to reach USD 7.84 billion by 2030, growing at a CAGR of 7.71% during the forecast period. This market plays a crucial role in the life sciences and biotechnology sectors, offering tools and technologies for analyzing gene expression in various biological samples. Gene expression analysis has become fundamental in applications ranging from drug discovery and clinical diagnostics to personalized medicine and academic research. A key growth factor is the rising demand for personalized treatment approaches, where gene expression profiling helps identify individual genetic signatures, enabling more precise and effective therapies. Technological advancements, particularly in high-throughput sequencing platforms like RNA-Seq, have significantly enhanced researchers' ability to investigate the transcriptome at an unprecedented scale. The adoption of these technologies has fueled a surge in biomedical research and collaboration among pharmaceutical firms, diagnostic developers, and research institutions. In oncology, gene expression tools are increasingly used to discover biomarkers and predict treatment responses, further accelerating the expansion of the market.

Key Market Drivers

Advancements in Sequencing Technologies

Technological progress in sequencing has been a critical driver of the Global Gene Expression Analysis Market. Next-generation sequencing (NGS), in particular, has transformed gene expression studies by offering high-throughput capabilities, greater sensitivity, and cost efficiency. NGS enables the simultaneous examination of thousands of genes across numerous samples, providing deeper insights into gene activity and regulation. These capabilities have broadened the use of gene expression profiling in personalized medicine, disease diagnostics, and fundamental research. The launch of high-capacity sequencers like Illumina's NovaSeq X Series, which can process over 20,000 whole genomes annually, exemplifies how enhanced throughput and reduced costs are making transcriptome analysis more accessible and widespread. This technological evolution is reshaping genomic research and reinforcing the market's long-term growth trajectory.

Key Market Challenges

Data Analysis Complexities

One of the significant hurdles in the Global Gene Expression Analysis Market is the complexity involved in managing and interpreting large-scale gene expression data. High-throughput methods, such as RNA-Seq, generate vast volumes of data that require sophisticated bioinformatics tools and computational infrastructure for effective analysis. The necessity for robust data processing pipelines-from quality control and alignment to normalization and differential expression analysis-adds layers of technical difficulty. Missteps at any stage can lead to inaccurate conclusions, undermining research validity. Additionally, the requirement for high-performance computing resources and specialized data analytics expertise presents a cost and skill barrier for many institutions, especially smaller laboratories and emerging markets. Addressing these analytical challenges is vital for maximizing the utility and reliability of gene expression studies.

Key Market Trends

Single-Cell RNA Sequencing (scRNA-Seq)

A prominent trend in the Global Gene Expression Analysis Market is the growing use of Single-Cell RNA Sequencing (scRNA-Seq). This cutting-edge technique enables researchers to profile gene expression at the individual cell level, revealing cellular heterogeneity that is otherwise masked in bulk RNA analyses. scRNA-Seq is transforming areas such as cancer biology, immunology, neuroscience, and developmental biology by allowing precise characterization of rare cell types and cellular states. This capability is driving a deeper understanding of disease mechanisms, progression, and treatment resistance. The rise of scRNA-Seq reflects a broader shift toward high-resolution, data-rich research tools that support more accurate and personalized scientific discoveries.

Key Market Players

• Merck KGaA
• Genscript Biotech Corporation
• Qiagen
• Bio-Rad Laboratories
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Agilent Technologies
• Lonza Group Ltd.
• New England Biolabs Inc

Report Scope:

In this report, the Global Gene Expression Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Expression Analysis Market, By Product Type:

• Instruments
• Services
• Others

Gene Expression Analysis Market, By Technique:

• RNA Expression
• Promotor Analysis
• Protein Expression & Post Translational Modification Expression
• Others

Gene Expression Analysis Market, By Application:

• Drug Discovery and Development
• Clinical Diagnostics
• Biotechnology and Microbiology
• Others

Gene Expression Analysis Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Government Research Institutes
• Others

Gene Expression Analysis Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gene Expression Analysis Market.

Available Customizations:

Global Gene Expression Analysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Gene Expression Analysis Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product Type (Instruments, Services, Others)
  • 4.2.2. By Technique (RNA Expression, Promotor Analysis, Protein Expression & Post Translational Modification Expression, Others)
  • 4.2.3. By Application (Drug Discovery and Development, Clinical Diagnostics, Biotechnology and Microbiology, Others)
  • 4.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Government Research Institutes, Others)
  • 4.2.5. By Region
  • 4.2.6. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product Type
  • 4.3.2. By Technique
  • 4.3.3. By Application
  • 4.3.4. By End User
  • 4.3.5. By Region

5. Asia Pacific Gene Expression Analysis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type
  • 5.2.2. By Technique
  • 5.2.3. By Application
  • 5.2.4. By End User
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Gene Expression Analysis Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product Type
      • 5.3.1.2.2. By Technique
      • 5.3.1.2.3. By Application
      • 5.3.1.2.4. By End User
  • 5.3.2. India Gene Expression Analysis Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product Type
      • 5.3.2.2.2. By Technique
      • 5.3.2.2.3. By Application
      • 5.3.2.2.4. By End User
  • 5.3.3. Australia Gene Expression Analysis Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product Type
      • 5.3.3.2.2. By Technique
      • 5.3.3.2.3. By Application
      • 5.3.3.2.4. By End User
  • 5.3.4. Japan Gene Expression Analysis Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product Type
      • 5.3.4.2.2. By Technique
      • 5.3.4.2.3. By Application
      • 5.3.4.2.4. By End User
  • 5.3.5. South Korea Gene Expression Analysis Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product Type
      • 5.3.5.2.2. By Technique
      • 5.3.5.2.3. By Application
      • 5.3.5.2.4. By End User

6. Europe Gene Expression Analysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Gene Expression Analysis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Germany Gene Expression Analysis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Spain Gene Expression Analysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User
  • 6.3.4. Italy Gene Expression Analysis Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By Technique
      • 6.3.4.2.3. By Application
      • 6.3.4.2.4. By End User
  • 6.3.5. United Kingdom Gene Expression Analysis Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By Technique
      • 6.3.5.2.3. By Application
      • 6.3.5.2.4. By End User

7. North America Gene Expression Analysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Gene Expression Analysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Mexico Gene Expression Analysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Canada Gene Expression Analysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User

8. South America Gene Expression Analysis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Gene Expression Analysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. Argentina Gene Expression Analysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Colombia Gene Expression Analysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User

9. Middle East and Africa Gene Expression Analysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 5.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Gene Expression Analysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Saudi Arabia Gene Expression Analysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. UAE Gene Expression Analysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Gene Expression Analysis Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Merck KGaA
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Genscript Biotech Corporation
• 14.3. Qiagen
• 14.4. Bio-Rad Laboratories
• 14.5. Takara Bio Inc.
• 14.6. Thermo Fisher Scientific, Inc.
• 14.7. Promega Corporation
• 14.8. Agilent Technologies
• 14.9. Lonza Group Ltd.
• 14.10. New England Biolabs Inc

15. Strategic Recommendations

16. About Us & Disclaimer